These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 360366)

  • 1. Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study.
    Tønnesen KH; Sager P; Gormsen J
    Scand J Clin Lab Invest; 1978 Sep; 38(5):431-5. PubMed ID: 360366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg.
    Lowe GD; Dunlop DJ; Lawson DH; Pollock JG; Watt JK; Forbes CD; Prentice CR; Drummond MM
    Angiology; 1982 Jan; 33(1):46-50. PubMed ID: 7036801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury.
    Simpson PJ; Schelm JA; Smith GF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):780-6. PubMed ID: 1704437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 7. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
    Sherman DG; Atkinson RP; Chippendale T; Levin KA; Ng K; Futrell N; Hsu CY; Levy DE
    JAMA; 2000 May; 283(18):2395-403. PubMed ID: 10815082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toe pressure measurements compared to ankle artery pressure measurements.
    Kröger K; Stewen C; Santosa F; Rudofsky G
    Angiology; 2003 Jan; 54(1):39-44. PubMed ID: 12593494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators.
    Stroke; 1994 Sep; 25(9):1755-9. PubMed ID: 8073455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in blood flow through a critical arterial stenosis by defibrination with ancrod.
    Barrie WW; Schenk WG
    Arch Surg; 1976 May; 111(5):561-3. PubMed ID: 1267605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ancrod in acute or progressing ischemic cerebral infarction.
    Olinger CP; Brott TG; Barsan WG; Hedges JR; Glas-Greenwalt P; Pollak VE; Spilker J; Eberle R
    Ann Emerg Med; 1988 Nov; 17(11):1208-9. PubMed ID: 3056131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation between toe- and ankle pressure, clinical symptoms and angiography in patients with leg ischemia].
    Friethriksson JO; Guethmundsson J; Logason K
    Laeknabladid; 2005 Oct; 91(10):749-53. PubMed ID: 16219974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of iloprost and factors affecting outcome in patients with severe inoperable lower limb ischaemia. U.K. Severe Limb Ischaemia Study Group.
    Belcher G
    Agents Actions Suppl; 1992; 37():354-60. PubMed ID: 1378690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation following defibrination with ancrod.
    Slade CL; Andes WA; Mason AD
    Thromb Haemost; 1976 Nov; 36(2):424-9. PubMed ID: 1036842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does placebo improve severe limb ischaemia?
    Vayssairat M; Baudot N; Sainte-Beuve C
    Lancet; 1988 Feb; 1(8581):356. PubMed ID: 2893161
    [No Abstract]   [Full Text] [Related]  

  • 18. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.